H.R. 9140 aims to enhance the process by which military medics transition into civilian healthcare jobs. It requires the Secretary of Defense and the Secretary of Homeland Security to implement improvements in the support and resources provided to these medics as they move into the civilian workforce, particularly in specific health care occupations. The bill also seeks to modify the assistance available to members of the armed forces who are separating from military service.
Supporters of H.R. 9140 have praised the bill for recognizing the valuable skills and experience that military medics possess. They argue that improving the transition process will not only benefit veterans but also address the growing demand for healthcare professionals in the civilian sector. The bill has been highlighted as a step towards enhancing veteran employment opportunities and ensuring that those who served their country can effectively continue their careers in health care.
Critics of H.R. 9140 have expressed concerns about the implementation of the proposed changes. Some argue that the bill may not adequately address the complexities of transitioning military medics into civilian roles, potentially overlooking the unique challenges faced by veterans. Additionally, there are worries about the effectiveness of the modified assistance programs and whether they will be sufficiently funded and supported to make a meaningful impact.
The analysis of H.R. 9140, sponsored by Maxine Dexter, reveals no direct industry overlaps between the sponsor's top donor industries and the bill's subject matter, which focuses on transitioning medics into civilian healthcare roles. The lobbying activity in this policy area includes contributions from various organizations, such as Paratek Pharmaceuticals ($20,000) and Steelships, LLC ($45,000), but these do not directly correlate with the bill's intent. The absence of significant financial ties between the sponsor's donors and the healthcare transition initiative suggests a low risk of conflicts of interest. Voters should be aware that while there is some lobbying activity, it does not appear to influence the bill's objectives significantly.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| STEELSHIPS, LLC | CONSCIENCE POINT CONSULTING, INC. | $45,000 |
| SAN PASQUAL BAND OF MISSION INDIANS | THE FARLEY GROUP, INC. | $30,000 |
| PARATEK PHARMACEUTICALS | PARATEK PHARMACEUTICALS | $20,000 |
| SAN JUAN SOUTHERN PAIUTE TRIBE | THE FARLEY GROUP, INC. | $15,000 |
| CHURCH ALLIANCE | K&L GATES, LLP | $10,000 |
| GIFDA | RULON & WHITE GOVERNANCE STRATEGIES | $10,000 |
| ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY | ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY | undisclosed |
| PHARMATROPHIX, INC. | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | undisclosed |
| PGA TOUR, INC. | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | undisclosed |
| RESPONSIVE GOV ACTION | THE RABEN GROUP | undisclosed |
| KERECIS | INVARIANT LLC | undisclosed |
| BINTI, INC. | INVARIANT LLC | undisclosed |
| VERTIV GROUP CORPORATION | AKIN GUMP STRAUSS HAUER & FELD | undisclosed |
| TERRA-GEN, LLC | AKIN GUMP STRAUSS HAUER & FELD | undisclosed |
| PHILIPS | CONTINENTAL STRATEGY, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Maxine Dexter, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
